The Group is the largest exporter of pharmaceuticals in Bangladesh with presence in 45 countries”

BEXIMCO manufactures and sells generic pharmaceutical formulation products, active pharmaceutical ingredients (API) and intravenous (IV) fluids. The Group’s product portfolio includes a variety of therapeutic areas, such as analgesics, antibiotics, cardiovascular, central nervous system, dermatology, gastroenterology and respiratory. It also has contract manufacturing agreements with global pharmaceutical firms. Selected customers include Asthma Drug Facility, GlaxoSmithKline, Raffles Hospital, UNICEF and UNESCO.

The Group is planning to expand manufacturing capacities in value added products such as inhalers, eye drops and sprays. Targeted global expansion areas include Middle East, European Union, Latin America, USA, Australia and New Zealand.

  Beximco Pharmaceuticals Ltd. Website